SPY343.38+1.37 0.40%
DIA282.95+0.92 0.33%
IXIC11,516.49+37.51 0.33%

JP Morgan Maintains Overweight on AbbVie, Raises Price Target to $120

JP Morgan maintains AbbVie (NYSE:ABBV) with a Overweight and raises the price target from $115 to $120.

· 10/16/2020 12:22
JP Morgan maintains AbbVie (NYSE:ABBV) with a Overweight and raises the price target from $115 to $120.